BioCentury
ARTICLE | Clinical News

Kadcyla trastuzumab emtansine: Phase III data

December 22, 2014 8:00 AM UTC

Top-line data from the 3-arm, double-blind, placebo-controlled, international Phase III MARIANNE (BO22589) trial in 1,095 previously untreated patients with HER2-positive advanced breast cancer showed...